PROSPECTS AND OPPORTUNITIES
Steady expansion, with pharmacies remaining dominant
Estonia’s analgesics market is set to expand steadily through 2030, driven by the continued preference for systemic ibuprofen and aspirin among adults and the rising uptake of paediatric formulations as young families become more health-conscious. Pharmacy-led channels will remain dominant; however, grocery and discount chains are securing incremental share by stocking private label products in smaller pack sizes, catering to consumers seeking basic relief at lower price points.
Innovative times ahead
Telehealth integration and e-prescriptions are transforming how Estonians access analgesics: digital consultation platforms now enable real-time pharmacist advice and automatic refill reminders, boosting adherence to chronic pain regimens. On the manufacturing front, companies are investing in continuous-flow reactors and AI-driven formulation screening to accelerate the launch of novel delivery systems such as micro-needle patches and precision-dosed oral films.
e-Prescription system ensures safer chronic pain management
Estonia’s paperless e-Prescription system, which has been operational since 2010, now accounts for 100% of all prescriptions, creating a unified digital record that pharmacies (via ID-card) and prescribers access in real time. This infrastructure underpins safer chronic pain management by enabling refill reminders and interaction checks.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Estonia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Estonia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Estonia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Estonia?
- Which are the leading brands in Analgesics in Estonia?
- How are products distributed in Analgesics in Estonia?
- How has the regulatory and operating environment for Analgesics changed in Estonia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Estonia - Category analysis
KEY DATA FINDINGS
Growth driven by a surge in low-dose, slow-release formulations for healthy ageing and cardiovascular wellness
Trend two
Professional advice and loyalty programmes ensure pharmacies maintain their dominance
Steady expansion, with pharmacies remaining dominant
Innovative times ahead
e-Prescription system ensures safer chronic pain management
Consumer Health in Estonia - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!